Drug Type Therapeutic vaccine |
Synonyms IPT 001, IPT001 |
Target |
Action inhibitors |
Mechanism ERV env inhibitors(Envelope ERV derived genes inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic dysfunction-associated steatotic liver disease | Preclinical | Denmark | 01 Jul 2025 | |
Non-Small Cell Lung Cancer | Preclinical | Denmark | 01 Jul 2025 | |
Prediabetic State | Preclinical | Denmark | 01 Jul 2025 | |
Pancreatic Cancer | Preclinical | Denmark | 01 Apr 2025 | |
Prostatic Cancer | Preclinical | Denmark | 01 Apr 2025 | |
Diabetes Mellitus, Type 2 | Discovery | Denmark | 01 Apr 2025 |